A Mytilus peptide related to the small cardioactive peptides (SCPs): structure determination and pharmacological...

1. An SCP-related peptide, Ala-Pro-Asn-Phe-Leu-Ala-Tyr-Pro-Arg-Leu-NH2, was isolated from the ABRMs of Mytilus edulis. The peptide was designated Mytilus SCP. 2. At 10(-10) M or higher, Mytilus SCP showed a potentiating effect on phasic contraction of the ABRM in response to repetitive electrical stimulation. In contrast, the peptide did not show any potentiating effect on contractures in response to ACh and the FMRFamide-related Mytilus decapeptide, suggesting that the potentiating effect on phasic contraction was brought about by an action of the peptide on the nerve elements in the ABRM. 3. At 10(-8) M or higher, Mytilus SCP showed a catch-relaxing effect in addition to the potentiating effect. The relaxing effect was blocked by mersalyl, suggesting that it was also brought about by a presynaptic action. 4. Various analogues of Mytilus SCP were examined on the ABRM. Leu-Ala-Tyr-Pro-Arg-Leu-NH2 was suggested to be the minimum structure required for both potentiating and relaxing activities on the ABRM. Leu-D-Ala-Tyr-Pro-Arg-D-Leu-NH2 and D-Leu-Ala-Tyr-Pro-Arg-D-Leu-NH2 were found to show strong potentiating and relaxing activities, though they were less potent than the Mytilus SCP.